z-logo
Premium
Antimicrobial peptides under clinical investigation
Author(s) -
Koo Hye Been,
Seo Jiwon
Publication year - 2019
Publication title -
peptide science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.533
H-Index - 7
ISSN - 2475-8817
DOI - 10.1002/pep2.24122
Subject(s) - antimicrobial peptides , antimicrobial , antibiotics , antibiotic resistance , clinical trial , medicine , intensive care medicine , drug resistance , pace , biology , microbiology and biotechnology , geodesy , geography
Overuse of conventional antibiotics as well as the slow pace of new antibiotic drug development leads to antimicrobial resistance (AMR). Because infections with multi‐drug resistant (MDR) pathogens have become a public health issue, the need for a novel class of antibiotics is urgent. Recently, antimicrobial peptides (AMPs) have emerged as a promising platform to fight against MDR bacteria ensuring broad‐spectrum antimicrobial activity and relatively low resistance emergence. Currently, a number of AMPs are undergoing clinical and preclinical trials against various infectious diseases. This review lists the 36 AMPs (27 clinical and 9 preclinical) with brief information about their origin, structure, mechanism, and development status. From the examples of AMPs under clinical investigation, we categorized several improvement strategies and highlighted directions for the future design of AMPs.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here